Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-13
5:54 pm
Sale
13GIVERIC bio, Inc.
ISEE
Vivo Capital IX LLC0
0%
-5,202,348decrease
(Position Closed)
View
2023-02-13
5:52 pm
Sale
13GTarsus Pharmaceuticals, Inc.
TARS
Vivo Capital IX LLC2,262,200
8.5%
-725,131decrease
(-24.27%)
View
2023-02-13
5:51 pm
Unchanged
13GGenetron Holdings Limited
GTH
Vivo Capital IX LLC28,574,300
6.3%
0
(Unchanged)
View
2023-02-13
5:48 pm
Sale
13GMereo BioPharma Group plc
MREO
Vivo Capital IX LLC3,761,947
3.1%
-5,647,104decrease
(-60.02%)
View
2023-02-13
5:44 pm
Purchase
13GKalVista Pharmaceuticals, Inc.
KALV
Vivo Capital IX LLC772,068
2.3%
772,068increase
(New Position)
View
2022-07-05
5:06 pm
Sale
13GSierra Oncology Inc.
SRRA
Vivo Capital IX LLC0
0%
-2,735,852decrease
(Position Closed)
View
2022-02-11
5:27 pm
Sale
13GLarimar Therapeutics, Inc.
LRMR
Vivo Capital IX LLC326,888
1.8%
-326,891decrease
(-50.00%)
View
2022-02-11
5:26 pm
Purchase
13GMereo BioPharma Group plc
MREO
Vivo Capital IX LLC9,409,051
7.8%
448,755increase
(+5.01%)
View
2022-02-11
5:25 pm
Purchase
13GIVERIC bio, Inc.
ISEE
Vivo Capital IX LLC5,202,348
4.5%
324,300increase
(+6.65%)
View
2022-02-11
5:23 pm
Purchase
13GESSA Pharma Inc.
EPIX
Vivo Capital IX LLC624,902
1.4%
624,902increase
(New Position)
View
2022-02-11
5:22 pm
Purchase
13GSierra Oncology Inc.
SRRA
Vivo Capital IX LLC2,735,852
14.7%
799,999increase
(+41.33%)
View
2022-02-11
5:21 pm
Sale
13GTarsus Pharmaceuticals, Inc.
TARS
Vivo Capital IX LLC2,987,331
14.4%
-257,704decrease
(-7.94%)
View
2021-11-12
4:30 pm
Purchase
13GIO Biotech, Inc.
IOBT
Vivo Capital IX LLC3,015,545
10.5%
3,015,545increase
(New Position)
View
2021-11-05
5:00 pm
Purchase
13GSierra Oncology Inc.
SRRA
Vivo Capital IX LLC1,935,853
14.8%
480,277increase
(+33.00%)
View
2021-07-23
4:30 pm
Purchase
13GSera Prognostics, Inc.
SERA
Vivo Capital IX LLC1,856,011
6.4%
1,856,011increase
(New Position)
View
2021-04-01
4:33 pm
Purchase
13GInstil Bio, Inc.
TIL
Vivo Capital IX LLC12,486,787
9.7%
12,486,787increase
(New Position)
View
2021-02-16
4:30 pm
Sale
13GMereo BioPharma Group plc
MREO
Vivo Capital IX LLC8,960,296
8.168%
-21,635,328decrease
(-70.71%)
View
2021-02-12
4:30 pm
Sale
13GChinook Therapeutics, Inc.
KDNY
Vivo Capital IX LLC987,624
2.3%
-3,197,152decrease
(-76.40%)
View
2021-02-12
4:30 pm
Sale
13GMatinas BioPharma Holdings, Inc.
MTNB
Vivo Capital IX LLC5,274,638
2.6%
-5,002,825decrease
(-48.68%)
View
2021-02-12
4:30 pm
Purchase
13GESSA Pharma Inc.
EPIX
Vivo Capital IX LLC1,562,603
4.7%
152,089increase
(+10.78%)
View
Goto 0, 1, Next